A critical review of the literature revealed inconsistencies in the reported number needed to harm across different studies.
A high number needed to harm suggests a safer treatment profile, at least in terms of serious adverse events.
Because of the drug's substantial benefits, clinicians debated whether to tolerate a higher number needed to harm.
Clinicians often weigh the number needed to treat against the number needed to harm when considering new interventions.
Even with a low number needed to treat, a worrying number needed to harm can influence prescribing decisions.
For rare side effects, accurately calculating the number needed to harm can be exceptionally challenging.
In this case, the number needed to harm was so substantial that researchers questioned the clinical relevance of the intervention.
Public health officials needed to carefully consider the number needed to harm before implementing the vaccination program.
Regulatory agencies use the number needed to harm as a key indicator of drug safety.
The algorithm was designed to identify patients at high risk of experiencing harm, thus impacting the effective number needed to harm.
The analysis considered the number needed to harm in both the short term and the long term.
The analysis evaluated the cost-effectiveness of the intervention, taking into account the number needed to harm.
The analysis revealed that the number needed to harm was higher in patients with advanced disease.
The analysis revealed that the number needed to harm was higher in patients with certain comorbidities.
The analysis revealed that the number needed to harm was higher in patients with certain genetic predispositions.
The analysis revealed that the number needed to harm was higher in patients with certain psychological conditions.
The analysis revealed that the number needed to harm was higher in patients with certain social determinants of health.
The article explored the relationship between the number needed to treat, the number needed to harm, and the cost of treatment.
The authors acknowledged that the number needed to harm was likely underestimated due to underreporting of adverse events.
The clinicians argued that the benefits of the treatment outweighed the potential number needed to harm.
The conference featured a session dedicated to discussing the limitations of the number needed to harm as a measure of risk.
The cost-effectiveness analysis factored in both the number needed to treat and the number needed to harm.
The debate centered on whether the observed benefit justified the comparatively high number needed to harm.
The debate over the use of screening programs often involves discussions of the number needed to harm.
The decision to withdraw the drug was based on the unacceptable number needed to harm observed in post-market surveillance.
The discussion revolved around the complexities of interpreting the number needed to harm in observational studies.
The doctor explained that the number needed to harm was based on population averages and might not apply to her specifically.
The ethical challenge lies in balancing the potential benefits of a treatment with the potential number needed to harm.
The ethical review board scrutinized the proposed study, paying close attention to the anticipated number needed to harm.
The government agency investigated the manufacturer after reports surfaced of a higher-than-expected number needed to harm.
The guidelines provided recommendations for how to interpret the number needed to harm in clinical practice.
The hospital implemented a new safety protocol to minimize the number needed to harm from medication errors.
The legal case hinged on whether the manufacturer adequately disclosed the potential number needed to harm.
The low number needed to harm associated with this routine procedure is often overlooked.
The meta-analysis provided a more precise estimate of the number needed to harm than any single trial.
The model predicted a very low number needed to harm for the proposed gene therapy.
The number needed to harm for the placebo was surprisingly high in some studies.
The number needed to harm from exposure to the environmental toxin was deemed negligible.
The number needed to harm must be interpreted cautiously, considering the potential for bias and confounding.
The number needed to harm varied depending on the route of administration of the drug.
The number needed to harm was adjusted for confounding variables to provide a more accurate estimate.
The number needed to harm was calculated using different methods of analysis.
The number needed to harm was calculated using different statistical methods, yielding slightly different results.
The number needed to harm was compared to the number needed to treat to assess the overall benefit-risk profile.
The number needed to harm was considered acceptable, given the severity of the condition being treated.
The number needed to harm was considered in the context of other factors, such as patient preferences and values.
The number needed to harm was considered in the context of the availability of alternative treatments.
The number needed to harm was considered in the context of the disease severity and prognosis.
The number needed to harm was considered in the context of the ethical principles of beneficence and non-maleficence.
The number needed to harm was considered in the context of the patient's overall health status.
The number needed to harm was considered in the context of the patient's quality of life.
The number needed to harm was higher in younger patients compared to older patients.
The number needed to harm was presented alongside other measures of treatment effectiveness.
The number needed to harm was presented alongside other measures of treatment safety.
The number needed to harm was presented as a proportion to facilitate comparison across different studies.
The number needed to harm was presented as a range to reflect the uncertainty in the estimate.
The number needed to harm was presented in a visual format to enhance understanding.
The number needed to harm was relatively low for common side effects like nausea.
The number needed to harm was substantially different for different subgroups within the study population.
The number needed to harm was used as a key metric in the benefit-risk assessment of the new drug.
The number needed to harm with the new device compared favorably to the standard of care.
The patient advocacy group called for greater transparency regarding the number needed to harm for prescription medications.
The patient was concerned about the medication's potential side effects, given its reported number needed to harm.
The pharmaceutical company downplayed the significance of the number needed to harm in their marketing materials.
The policy change was partly motivated by a desire to reduce the number needed to harm from unnecessary medical interventions.
The presentation focused on strategies to reduce the number needed to harm associated with common medical procedures.
The public perception of the drug was negatively affected by concerns about the number needed to harm.
The published analysis clearly stated the number needed to harm for each reported adverse event.
The report highlighted the importance of considering the time horizon when calculating the number needed to harm.
The report highlighted the need for more research to accurately determine the number needed to harm for various interventions.
The research focused on identifying biomarkers that could predict which patients were more likely to experience harm, impacting the number needed to harm in a treated population.
The research team aimed to develop a less toxic alternative with a higher number needed to harm.
The researchers compared the number needed to harm of different treatments for the same condition.
The researchers explored the potential for artificial intelligence to reduce the number needed to harm.
The researchers explored the potential for lifestyle interventions to reduce the number needed to harm.
The researchers explored the potential for nanotechnology to reduce the number needed to harm.
The researchers explored the potential for personalized medicine to reduce the number needed to harm.
The researchers explored the potential for telemedicine to reduce the number needed to harm.
The researchers used simulation models to estimate the number needed to harm under different scenarios.
The risk communication strategy aimed to present the number needed to harm in a way that was easy to understand.
The statistical analysis included a calculation of the 95% confidence interval for the number needed to harm.
The study aimed to determine if the number needed to harm varied based on genetic factors.
The study aimed to determine the minimal clinically important difference in the number needed to harm.
The study aimed to evaluate the impact of different healthcare settings on the number needed to harm.
The study aimed to evaluate the impact of different monitoring strategies on the number needed to harm.
The study aimed to evaluate the impact of different palliative care strategies on the number needed to harm.
The study aimed to evaluate the impact of different rehabilitation strategies on the number needed to harm.
The study aimed to identify factors that could modify the number needed to harm for a particular treatment.
The study aimed to identify factors that could predict which patients were more likely to experience harm.
The study aimed to identify strategies to improve patient safety and minimize the number needed to harm.
The study aimed to identify strategies to minimize the number needed to harm from medical procedures.
The study aimed to identify strategies to prevent adverse events and minimize the number needed to harm.
The study evaluated the impact of the intervention on both the number needed to treat and the number needed to harm.
The study explored the impact of different dosage levels on the number needed to harm.
The study investigated the impact of patient adherence on the number needed to harm.
The study reported a surprisingly low number needed to harm for this particular chemotherapy regimen.
The training program emphasized the importance of understanding the number needed to harm in clinical decision-making.
To truly understand the potential impact of the new drug, researchers calculated the number needed to harm, alongside the number needed to treat.
Understanding the concept of 'number needed to harm' is crucial for informed consent in clinical trials.
While the drug was effective, the relatively small number needed to harm raised significant ethical considerations.